Therapy Discontinuation after Myocardial Infarction

Therapy Discontinuation after Myocardial Infarction

The discontinuation of recommended therapy after myocardial infarction predisposes patients to serious thrombotic complications. The aim of this study was a comprehensive analysis of permanent as well as short- and long-term discontinuation of pharmacotherapy, taking into consideration the basic gro...

Full description

Bibliographic Details
Main Authors:	Łukasz Pietrzykowski, Michał Kasprzak, Piotr Michalski, Agata Kosobucka, Tomasz Fabiszak, Aldona Kubica
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Journal of Clinical Medicine
Subjects:	adherence myocardial infarction angiotensin converting enzyme inhibitors (ACEI) P2Y<sub>12 </sub>receptor inhibitors statins
Online Access:	https://www.mdpi.com/2077-0383/9/12/4109

Similar Items

Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
by: Nicola Bonner, et al.
Published: (2017-05-01)

Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study
by: Shih-Yi Lin, et al.
Published: (2020-03-01)

Recurrent Severe Angioedema Associated with Imidapril and Diclofenac
by: Thatchai Kampitak
Published: (2008-01-01)

The Effect of Enalapril on Anti-inflammatory Cytokines in Patients with Migraine: A Double-Blind, Randomized Clinical Trial
by: Shaghayegh Haghjooy Javanmard, et al.
Published: (2013-06-01)

Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction
by: Kosobucka A, et al.
Published: (2018-03-01)

Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective
by: Hee-Sung Kim, et al.
Published: (2021-02-01)

Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis
by: Qiong Ling, et al.
Published: (2018-02-01)

Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
by: A. S Galyavich
Published: (2010-03-01)

Appropriateness of Repeated Clinical Alerts to Add Angiotensin Converting Enzyme Inhibitor Therapy in Diabetic Patients with Medicare Part D Coverage
by: Hryshko, Patrick, et al.
Published: (2014)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
by: Wenjun Wang, et al.
Published: (2021-01-01)

THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR?
by: S. Yu. Martsevich
Published: (2016-01-01)

Proteinuria: pathophysiology, diagnostic and therapeutic approach
by: Enrico Valvo
Published: (2013-04-01)

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
by: Patrick Bidulka, et al.
Published: (2020-07-01)

Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies
by: Claudio Borghi, et al.
Published: (2018-06-01)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
by: David S. Fedson, et al.
Published: (2020-05-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19
by: Enrique Rodilla, et al.
Published: (2020-09-01)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
by: Kim J, et al.
Published: (2016-09-01)

How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
by: Dickstein Kenneth, et al.
Published: (2001-06-01)

Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic review
by: Chinonyerem O. Iheanacho, et al.
Published: (2021-03-01)

Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)
by: K. G Pereverzeva, et al.
Published: (2017-09-01)

Combination of LCZ696 and ACEI further improves heart failure and myocardial fibrosis after acute myocardial infarction in mice
by: Youbin Liu, et al.
Published: (2021-01-01)

Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs)
by: Paranjpe R, et al.
Published: (2020-10-01)

Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies
by: Borghi C, et al.
Published: (2018-07-01)

Effects of angiotensin converting enzyme inhibitors on cognitive function, apoptosis and oxidative stress in brain tissue of rats with cerebral infarction
by: Xin Bian, et al.
Published: (2019-11-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Effect of angiotensin receptor neprilysin inhibitor on ventricular remodeling after myocardial infarction in rats
by: Jian An
Published: (2020-11-01)

Levels of vascular endothelial growth factor during first six months of peritoneal dialysis
by: Stojimirović Biljana, et al.
Published: (2015-01-01)

Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study
by: Francisco J. de Abajo, et al.
Published: (2021-05-01)

Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up
by: Xuhe Gong, et al.
Published: (2018-12-01)

No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort
by: Gian Paolo Anzola, et al.
Published: (2020-09-01)

Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome
by: Yue Zhang, et al.
Published: (2020-04-01)

Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
by: Hun-Sung Kim, et al.
Published: (2018-12-01)

Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury
by: Mingfei Li, et al.
Published: (2020-03-01)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
by: M. M. Loukianov, et al.
Published: (2017-05-01)

Rat angiotensin-converting enzyme : tissue specific expression during pharmacological inhibition
by: Brice, Edmund Andrew William
Published: (2018)

Administration of Tranexamic Acid as Treatment for Angiotensin Converting Enzyme Inhibitor-Induced Angioedema: A Case Report
by: Sohun Awsare, et al.
Published: (2021-07-01)

2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
by: Luigi Cappannoli, et al.
Published: (2020-12-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)